Course ID: 2809
This session will focus on four common causes of PAH around the world. From a global perspective, schistosomiasis is the most common cause for PH, with HIV and chronic high-altitude exposure closely behind. Drug- and toxin-exposure however, has been identified as a specific problem in the western world. This class will highlight the key features of these particular types of PH/PAH, review both established and emerging paradigms, and discuss their implications on a global platform.
Ghazwan Butrous, MB, ChB, Ph.D., FESC, FRSA
University of Kent
Christopher Barnett, M.D., MPH
Medstar Washington Hospital Center
Drug and Toxins
Vinicio de Jesus Perez, M.D.
Erik R. Swenson, M.D.
University of Washington, Seattle
George J. Vuturo, Ph.D., RPh
Chief Compliance Officer
Planning Committee Member
Professional Education Services Group, LLC, Sterling, VA
Janice Agazio, Ph.D., CRNP, RN, FAANP, FAAN
Lead Nurse Planner Planning Committee Member Professional Education Services Group, LLC,
Sterling, VA Assistant Dean for Doctoral Programs and Ordinary Professor School
of Nursing the Catholic University of America, Washington, DC
CME/CE Project Director
Professional Education Services Group, LLC, Sterling, VA
This continuing education activity provides continuing education (CE) credits for:
- Pharmacists and Pharmacy Technicians
- Respiratory Therapists
- Social Workers
- Other Related Health Professionals
At the conclusion of this activity participants should be able to:
- Understand the pathology of PH associated with schistosomiasis, HIV drugs and toxins, and high altitude.
- Learn about the current research activities on schistosomiasis-associated PH and its impact on understanding the role of information on pulmonary vascular diseases.
- Discuss treatment options for HIV-associated PAH.
- Review the global impact and discuss recent genetic insights concerning the pathogenesis of drug and toxin PAH.
- Understand how acute excessive hypoxic pulmonary vasoconstriction (HPV) and other factors can lead to high-altitude pulmonary edema (HAPE).
February 2, 2017
December 31, 2017
Estimated Time to Complete This Activity
Continuing Education Information
This continuing education activity is provided through a joint Providership Agreement between The Pulmonary Hypertension Association (PHA) and Professional Education Services Group (PESG). This activity will provide continuing education for nurses, pharmacists, respiratory therapists, and social workers. All other health care professionals completing this continuing education activity will be issued Certificate of Attendance which may be submitted to accrediting organizations or licensing boards to meet CE requirements.
- This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of Professional Education Services Group and the Pulmonary Hypertension Association. Professional Education Services Group is accredited by the ACCME to provide continuing medical education for physicians. This activity has been approved for a maximum of 1.0 hours of AMA PRA Category 1 Credits™. Physicians should only claim credit to the extent of their participation.
- Professional Education Services Group is an accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides a maximum of 1.0 contact hours of nurse CE credit.
Pharmacists and Pharmacy Technicians
- Professional Education Services Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE UAN 0829-0000-16-181-L04 (Pharmacists) and 0829-0000-16-181-L04 (Pharmacy Technicians). This activity provides 1.0 contact hours (0.10 CEUs) of continuing education credit. There is no cost for this activity. Your record of completion will be reported directly to the CPE Monitor.
- The Continuing Respiratory Education (CRCE) system of the American Association for Respiratory Care (AARC) grants approval for 1.0 hours for this course.
- This program is approved by the National Association of Social Workers for 1.0 Social Work continuing education contact hours.
Instructions for Earning Credit
This activity is a self-study program. In order to claim CE credit, participants must:
- View the content, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be directed to the CE processing center at http://pha.cds.pesgce.com and claim CE credit.
- Complete a post-test and evaluation online. All evaluation questions must be completed in order to receive a CE credit.
- Upon successful completion of the post-test and online evaluation form, you can instantly download and/or print your certificate of credit. Your CE records will be stored at http://pha.cds.pesgce.com for later retrieval at your convenience.
For all CE related inquiries, please contact Support@PESGCE.com or PHA Online University at (301)-565-3004-x771.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Professional Educational Services Group (PESG) to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty and planners of this educational activity disclose the following:
- Christopher Barnett, M.D., MPH, has not provided a disclosure
- Erik R. Swenson, M.D., has no financial or non-financial arrangements, or affiliations to disclose.
- Ghazwan Butrous, MB, ChB, Ph.D., FESC, FRSA, has no financial or non-financial arrangements, or affiliations to disclose.
- Vinicio de Jesus Perez, M.D., has no financial or non-financial arrangements, or affiliations to disclose.
The information presented in this activity reflects the views of the faculty only and not necessarily those of the Pulmonary Hypertension Association (PHA), the sponsors or the educational grant providers. All participants should verify the information and data presented before treating patients or utilizing any therapies noted in these materials. No portion of this activity may be reproduced without the expressed written consent of PHA.
This course requires an internet browser. For optimum display, please use Mozilla Firefox, Safari or Google Chrome.
This enduring activity is made possible through unrestricted educational grants to the PHA Medical Education Fund from Actelion Pharmaceuticals, US; Gilead Sciences, Bayer HealthCare, and United Therapeutics.
©2016 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.